(0.09%) 5 522.00 points
(0.12%) 39 892 points
(0.22%) 19 793 points
(-0.01%) $81.62
(0.57%) $2.83
(-0.30%) $2 337.30
(-0.02%) $29.52
(0.25%) $1 004.30
(0.00%) $0.931
(-0.04%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
-1.10% $ 19.80
Live Chart Being Loaded With Signals
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease...
Stats | |
---|---|
Dzisiejszy wolumen | 860 126 |
Średni wolumen | 811 314 |
Kapitalizacja rynkowa | 949.93M |
EPS | $0.580 ( Q1 | 2024-05-10 ) |
Następna data zysków | ( $-0.440 ) 2024-08-01 |
Last Dividend | $5.25 ( 2012-12-13 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-9.12 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0240 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-20 | Barbier Remi | Buy | 50 000 | Stock Option (Right to Buy) |
2024-05-20 | Schoen Eric | Buy | 25 000 | Stock Option (Right to Buy) |
2024-05-20 | Cook Robert Christopher | Buy | 10 000 | Stock Option (Right to Buy) |
2024-05-20 | Kupiec James William | Buy | 10 000 | Stock Option (Right to Buy) |
2024-05-16 | Robertson Sanford | Sell | 5 000 | Common Stock |
INSIDER POWER |
---|
74.90 |
Last 93 transactions |
Buy: 2 627 968 | Sell: 532 470 |
Wolumen Korelacja
Cassava Sciences Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cassava Sciences Inc Korelacja - Waluta/Towar
Cassava Sciences Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.53M (0.00 %) |
EPS: | $-2.32 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.53M (0.00 %) |
EPS: | $-2.32 |
FY | 2022 |
Przychody: | $-1 800.00 |
Zysk brutto: | $-1.30M (72 377.78 %) |
EPS: | $-1.800 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.820 |
Financial Reports:
No articles found.
Cassava Sciences Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $14.00 | 2010-12-13 |
Last Dividend | $5.25 | 2012-12-13 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-24 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $19.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $14.00 | 37.20% |
2011 | $0 | 0.00% |
2012 | $5.25 | 19.20% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
13 Dec 2012 | $5.25 | 08 Dec 2012 | 17 Dec 2012 | 24 Dec 2012 |
13 Dec 2010 | $14.00 | 25 Oct 2010 | 01 Dec 2010 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -20.40 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.308 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.348 | 1.500 | -4.98 | -7.47 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.738 | 0.800 | 6.31 | 5.05 | [1 - 3] |
quickRatioTTM | 1.623 | 0.800 | 5.16 | 4.13 | [0.8 - 2.5] |
cashRatioTTM | 1.610 | 1.500 | 2.17 | 3.25 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -37.76 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -2.04 | 2.00 | -0.681 | -1.363 | [0 - 30] |
freeCashFlowPerShareTTM | -2.05 | 2.00 | -1.023 | -2.05 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.382 | 1.000 | 6.96 | 6.96 | [0.2 - 0.8] |
operatingProfitMarginTTM | -42.33 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0151 | 0.800 | -3.23 | -2.59 | [0.5 - 2] |
Total Score | -3.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -17.97 | 1.000 | -1.916 | 0 | [1 - 100] |
returnOnEquityTTM | -0.348 | 2.50 | -3.20 | -7.47 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -2.05 | 2.00 | -0.682 | -2.05 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -2.04 | 2.00 | -0.681 | -1.363 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 3.23 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -37.43 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -1.264 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cassava Sciences Inc
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej